Beaird Harris Wealth Management’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.2K Hold
200
﹤0.01% 290
2026
Q1
$19K Hold
200
﹤0.01% 316
2025
Q4
$32.9K Hold
200
﹤0.01% 293
2025
Q3
$20.7K Hold
200
﹤0.01% 326
2025
Q2
$24.9K Sell
200
-500
-71% -$64.6K ﹤0.01% 312
2025
Q1
$32.9K Sell
700
-600
-46% -$29.3K ﹤0.01% 262
2024
Q4
$41.2K Sell
1,300
-1,900
-59% -$54.1K ﹤0.01% 242
2024
Q3
$69.4K Buy
+3,200
New +$46.1K 0.01% 206
2024
Q2
Sell
-5,201
Closed -$74.8K 774
2024
Q1
$74.8K Sell
5,201
-1,001
-16% -$20.1K 0.01% 172
2023
Q4
$167K Buy
6,202
+4,201
+210% +$131K 0.02% 114
2023
Q3
$60.8K Sell
2,001
-4,186
-68% -$202K 0.01% 160
2023
Q2
$391K Buy
+6,187
New +$531K 0.05% 65
2023
Q1
Sell
-2,780
Closed -$563K 483
2022
Q4
$792K Buy
+2,780
New +$534K 0.15% 42

Other funds holding NUTX

Beaird Harris Wealth Management's NUTX Position: Q2 2026 in Review

Beaird Harris Wealth Management held its Nutex Health (NUTX) position steady in Q2 2026 at 200 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #290.

Beaird Harris Wealth Management first reported a position in NUTX in Q4 2022 and has held it in 13 quarters since. The position peaked at $792K in Q4 2022. 7 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Beaird Harris Wealth Management held 200 shares of Nutex Health worth $34.2K as of Q2 2026.
  • Beaird Harris Wealth Management left its Nutex Health share count unchanged in Q2 2026.
  • Nutex Health made up ﹤0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #290 holding.
  • Beaird Harris Wealth Management first reported a position in Nutex Health in Q4 2022 and has held it in 13 quarters since.
  • Beaird Harris Wealth Management's Nutex Health position peaked at $792K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.